Sevim Işık

1.3k total citations · 1 hit paper
33 papers, 950 citations indexed

About

Sevim Işık is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Sevim Işık has authored 33 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Biomaterials and 6 papers in Biomedical Engineering. Recurrent topics in Sevim Işık's work include Advanced biosensing and bioanalysis techniques (6 papers), RNA Interference and Gene Delivery (5 papers) and Cancer therapeutics and mechanisms (4 papers). Sevim Işık is often cited by papers focused on Advanced biosensing and bioanalysis techniques (6 papers), RNA Interference and Gene Delivery (5 papers) and Cancer therapeutics and mechanisms (4 papers). Sevim Işık collaborates with scholars based in Türkiye, Japan and United States. Sevim Işık's co-authors include Merve Zaim, Güven Çetin, Mehmet Şenel, Serap Karaman, Muamer Dervisevic, Wolfgang Metzger, Güven Çetin, Ramazan Öztürk, Z. Durmuş and Belma Zengin Kurt and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Food Chemistry.

In The Last Decade

Sevim Işık

31 papers receiving 940 citations

Hit Papers

Microglia Mediated Neuroinflammation in Parkinson’s Disease 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sevim Işık Türkiye 13 355 238 195 170 117 33 950
Jihui Wang China 21 745 2.1× 292 1.2× 75 0.4× 202 1.2× 108 0.9× 61 1.5k
David Y.B. Deng China 22 454 1.3× 179 0.8× 121 0.6× 240 1.4× 152 1.3× 48 1.4k
Gang Deng China 20 702 2.0× 301 1.3× 70 0.4× 276 1.6× 78 0.7× 47 1.3k
Guangfan Chi China 23 980 2.8× 370 1.6× 146 0.7× 122 0.7× 121 1.0× 49 1.9k
Hyun Ju Ko South Korea 13 270 0.8× 296 1.2× 146 0.7× 341 2.0× 61 0.5× 23 942
Yuanyin Wang China 17 295 0.8× 501 2.1× 136 0.7× 219 1.3× 114 1.0× 56 1.1k
Liang‐Yo Yang Taiwan 16 396 1.1× 602 2.5× 65 0.3× 232 1.4× 155 1.3× 25 1.3k
Hongkwan Cho United States 21 597 1.7× 145 0.6× 70 0.4× 276 1.6× 103 0.9× 34 1.3k
Kaili Mao China 17 353 1.0× 340 1.4× 60 0.3× 403 2.4× 99 0.8× 50 1.2k
Yin Zhang China 12 310 0.9× 216 0.9× 50 0.3× 116 0.7× 104 0.9× 46 1.1k

Countries citing papers authored by Sevim Işık

Since Specialization
Citations

This map shows the geographic impact of Sevim Işık's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sevim Işık with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sevim Işık more than expected).

Fields of papers citing papers by Sevim Işık

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sevim Işık. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sevim Işık. The network helps show where Sevim Işık may publish in the future.

Co-authorship network of co-authors of Sevim Işık

This figure shows the co-authorship network connecting the top 25 collaborators of Sevim Işık. A scholar is included among the top collaborators of Sevim Işık based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sevim Işık. Sevim Işık is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Işık, Sevim, et al.. (2025). Plant-derived exosome-like nanovesicles: mechanisms and molecular understanding in neurological disorders with potential therapeutic applications. Drug Delivery and Translational Research. 15(12). 4452–4478. 1 indexed citations
2.
Işık, Sevim, et al.. (2024). Competitive Inhibition and Synergistic Effects of Nutraceutical and Metabolite Molecules on Anti-Acetylcholinesterase Activity. Journal of the Turkish Chemical Society Section A Chemistry. 11(2). 575–584. 1 indexed citations
4.
Işık, Sevim, et al.. (2023). Microglia Mediated Neuroinflammation in Parkinson’s Disease. Cells. 12(7). 1012–1012. 174 indexed citations breakdown →
5.
Işık, Sevim, et al.. (2023). Enhancing CAR-T cells: unleashing lasting impact potential with phytohemagglutinin activation in in vivo leukemia model. Cancer Gene Therapy. 31(3). 387–396. 1 indexed citations
6.
Işık, Sevim, et al.. (2023). Proposing novel natural compounds against Alzheimer’s disease targeting acetylcholinesterase. PLoS ONE. 18(4). e0284994–e0284994. 12 indexed citations
7.
Şenel, Mehmet, et al.. (2022). Folic acid conjugated PAMAM-modified mesoporous silica-coated superparamagnetic iron oxide nanoparticles for potential cancer therapy. Journal of Colloid and Interface Science. 625. 711–721. 35 indexed citations
9.
Neğiş, Yeşim, et al.. (2017). Cellular Model of Alzheimer's Disease: Aβ1-42 Peptide Induces Amyloid Deposition and a Decrease in Topo Isomerase IIβ and Nurr1 Expression. Current Alzheimer Research. 14(6). 636–644. 21 indexed citations
10.
Işık, Sevim, et al.. (2017). Preparation and characterization of amine functional nano-hydroxyapatite/chitosan bionanocomposite for bone tissue engineering applications. Carbohydrate Polymers. 164. 200–213. 91 indexed citations
11.
Dervisevic, Muamer, et al.. (2017). Boronic Acid vs. Folic Acid: A Comparison of the bio-recognition performances by Impedimetric Cytosensors based on Ferrocene cored dendrimer. Biosensors and Bioelectronics. 91. 680–686. 23 indexed citations
12.
Dervisevic, Muamer, et al.. (2016). Highly sensitive detection of cancer cells with an electrochemical cytosensor based on boronic acid functional polythiophene. Biosensors and Bioelectronics. 90. 6–12. 59 indexed citations
13.
Durmuş, Z., et al.. (2015). Preparation and in vitro evaluation of 5-flourouracil loaded magnetite–zeolite nanocomposite (5-FU-MZNC) for cancer drug delivery applications. Biomedicine & Pharmacotherapy. 77. 182–190. 60 indexed citations
14.
Işık, Sevim, et al.. (2014). Delivery of lipophilic porphyrin by liposome vehicles: Preparation and photodynamic therapy activity against cancer cell lines. Photodiagnosis and Photodynamic Therapy. 11(4). 537–545. 44 indexed citations
15.
Işık, Sevim, et al.. (2014). DNA topoisomerase IIβ as a molecular switch in neural differentiation of mesenchymal stem cells. Annals of Hematology. 94(2). 307–318. 16 indexed citations
16.
Işık, Sevim, et al.. (2014). Influence of gold nanoparticle architecture on in vitro bioimaging and cellular uptake. Journal of Nanoparticle Research. 16(12). 10 indexed citations
17.
Gencer, Salih, et al.. (2012). Photodynamic activities of protoporphyrin IX and its dopamine conjugate against cancer and bacterial cell viability. Medicinal Chemistry Research. 21(12). 4499–4505. 5 indexed citations
18.
Tsutsui, Ken‐Ichiro, et al.. (2011). Selective silencing of DNA topoisomerase IIβ in human mesenchymal stem cells by siRNAs (small interfering RNAs). PubMed. 18(1). 15–21. 12 indexed citations
19.
Mammadov, Büşra, et al.. (2011). Comparison of long-term retinoic acid-based neural induction methods of bone marrow human mesenchymal stem cells. In Vitro Cellular & Developmental Biology - Animal. 47(7). 484–491. 12 indexed citations
20.
Işık, Sevim, Kuniaki Sano, Kimiko Tsutsui, et al.. (2003). The SUMO pathway is required for selective degradation of DNA topoisomerase IIβ induced by a catalytic inhibitor ICRF‐1931. FEBS Letters. 546(2-3). 374–378. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026